TargetMol Chemicals Inc.회사는 제품 목록을 제공합니다.

회사 명:TargetMol Chemicals Inc.

전화:-

이메일:marketing@targetmol.com

국적:China

총 제품 수:19696

72 73 74 75 76 77 78 79 80 81 82 83 84 85 86 87 88 89 90 91 92 93 94 95 96 97 98 99 100 101 102 103 104 105 106 107 108 109 110 111 112 113 114 115 116 117 118 119 120 121 122 123 124 125 126 127 128 129 130 131 132 133 134 135 136 137 138 139 140 141 142 143 144 145 146 147 148 149 150 151 152 153 154 155 156 157 158 159 160 161 162 163 164 165 166 167 168 169 170 171 172 173 174 175 176

제품 카탈로그

RSS0680		2769753-48-0	C52H64N10O6S3
P 218		1142407-60-0	C18H25ClN4O4
HA5		2378406-17-6	C15H10O5
P-gb-IN-1		2632874-49-6
Brentuximab		2088770-90-3
Moiramide B		155233-31-1	C25H31N3O5
AC 7739		162705-22-8	C18H21NO4.ClH
Glembatumumab vedotin		1182215-65-1
Inotuzumab		1660159-36-3
RSH-7		2764609-97-2	C22H25FN8O
Ebaresdax hydrochloride		1334385-87-3	C12H15ClN2O3S
AP-C2		682793-07-3	C18H16N4S
NP10679		2914889-88-4
PARP1/2/TNKS1/2-IN-1		2243453-32-7
TGFβ1-IN-3		2883813-58-7
Zilovertamab		1643432-38-5
ZIM		301298-87-3	C20H19N3O3
Angiotensin 1/2 (1-9) TFA
MitoSOX Red		1003197-00-9	C43H43IN3P
SOS1-IN-15		2793404-47-2	C28H27F3N6O2
Myosin V-IN-1		1259177-59-7	C29H26N6O3S
R 59-022 hydrochloride		93076-98-3	C27H27ClFN3OS
PF-17		2697145-21-2	C21H28N4O5S
lorvotuzumab		339306-30-8
PARP-2-IN-3		2915650-86-9
OTUB1/USP8-IN-1		2858800-98-1	C22H16ClFN2O4
GW297361		388627-21-2	C16H12N4O3S2
HDAC-IN-57		2716217-79-5	C21H19N3O4
pCDPK1/TgCDPK1-IN-3		1092788-87-8	C17H18N6
AUTAC1		2241669-09-8
Larotinib		1438072-11-7	C24H26ClFN4O4
TV 3279		209394-29-6	C16H20N2O2
Nurr1 agonist 2		742058-34-0	C18H14O3S
Cibisatamab		1855925-27-7
(Rac)-SHIN2		2204289-53-0	C23H26N4O3
DC-BPi-03		2758411-46-8	C14H14N4O2S
p53 Activator 7		2849340-59-4	C27H32F3N4OP
Sonepcizumab		1031360-18-5
DATPT		2891582-75-3	C24H38N6O3.ClH
USP28-IN-3		2931509-14-5
Senktide acetate
GSK3-IN-3		331963-27-0	C24H35N3O4
SMN-C2		1446311-56-3	C24H27N5O2
Pincainide	핀카이니드	83471-41-4	C16H24N2O
TNF-α-IN-9		2054199-25-4	C17H14O4
Theralizumab		906068-56-2
Clivatuzumab		1622075-09-5
Akt3 degrader 1		2836342-69-7	C53H72N8O4
Xanthine oxidoreductase-IN-5		1026652-90-3	C17H17N5O2
FC-116		2417298-29-2
PLH1215		1332084-64-6
Xanthine oxidoreductase-IN-3		651769-78-7	C14H10ClN5O
PCSK9-IN-10		368434-98-4	C18H23N5O4
APOBEC3G-IN-1		14261-92-8	C15H11NO3
CYP4A11/CYP4F2-IN-1		502654-40-2	C15H15N3OS
PU.1-IN-1		873588-27-3	C18H22N2O2S
DPTN dihydrochloride		325767-87-1	C22H18N4OS.2ClH
ccc_R08		2919019-72-8	C22H19ClO6
SARS-CoV-2-IN-39		2882823-03-0
BCAT-IN-4		406190-85-0
Ordesekimab		879293-15-9
BCPA		547731-67-9	C22H22Cl2N2O2
SF-22	N-(비페닐-2-일)-3-(N-(2,5-디메틸페닐)술파모일)-4-메틸벤자미드	824981-55-7	C28H26N2O3S
SID-852843		909859-19-4	C17H15N3O5S
A2B receptor antagonist 2 hydrochloride		724-70-9	C12H15N5.ClH
(R)-HH2853		2202678-06-4	C31H36F3N7O3
11β-HSD1 inibitor 19		946400-19-7	C19H16ClF4N3O2S
CYP1B1-IN-5		176442-56-1	C14H8INO2
AXL-IN-13		2376928-82-2	C34H41FN6O5
MyD88-IN-1		2911609-80-6	C23H24N6O7S
CpG ODN 10101		1234402-77-7
STING agonist-30		2951078-67-2
GSNKGAIIGLM(131602-53-4(free base))		131602-53-4	C45H81N13O14S
CLK8		898920-65-5	C29H26N2O6
(R)-BI-2852		2375482-49-6	C31 H28 N6 O2
SFI003		2361332-90-1	C19H17N5OS
Dazostinag disodium		2553413-93-5	C21H23F2N8NaO10P2S2
STC314		186295-19-2	C13H25NaO32S7
Enfortumab		1448664-46-7
Cbl-b-IN-5		2368835-59-8	C17H17N5OS
PLH2058		2525206-41-9
Atibeprone	아이티프론	153420-96-3	C17H18N2O3S
ENT-C225		2919962-53-9
TJ08		2924274-19-9
Endo-1,3-β-glucanase	키탈라제	9025-37-0
PDCD4-IN-1		494763-64-3	C12H9BrClN3O
Bivatuzumab		214559-60-1
JNJ-49095397		1220626-82-3	C34H36N6O4
GRGDSPK acetate		144027-77-0
NSC243928 mesylate		59988-01-1
DSPE-NHS		1383932-86-2	C49H89N2O13P
SRI-42127		2727872-68-4	C19H20N6O
Nampt activator-2		2237268-90-3	C17H15ClN4O3S
hCAII-IN-9		2878477-18-8	C15H16ClN3O5S2
PRMT6-IN-3		2890765-10-1	C19H26N4O2S
TGFβ1-IN-2		2700263-58-5	C23H30N4O4S
BPDA2		2907659-86-1
CZL55		667408-87-9	C20H22N2O6
[Sar1, Ile8]-Angiotensin II 3TFA		37827-06-8	C46H73N13O10
[Leu5]-Enkephalin acetate(58822-25-6 free base)		58822-25-6	C28H37N5O7